Cargando…
Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel
Heterozygous familial hypercholesterolaemia (FH) is among the most common genetic metabolic lipid disorders characterised by elevated low-density lipoprotein cholesterol (LDL-C) levels from birth and a significantly higher risk of developing premature atherosclerotic cardiovascular disease. The majo...
Autores principales: | Bjelakovic, Bojko, Stefanutti, Claudia, Reiner, Željko, Watts, Gerald F., Moriarty, Patrick, Marais, David, Widhalm, Kurt, Cohen, Hofit, Harada-Shiba, Mariko, Banach, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585021/ https://www.ncbi.nlm.nih.gov/pubmed/34768450 http://dx.doi.org/10.3390/jcm10214930 |
Ejemplares similares
-
Lipid profile and left ventricular geometry pattern in obese children
por: Bjelakovic, Bojko, et al.
Publicado: (2020) -
Hypercholesterolaemia – practical information for non-specialists
por: Soran, Handrean, et al.
Publicado: (2017) -
Awareness and knowledge of heterozygous familial hypercholesterolemia among Serbian pediatricians
por: Bjelakovic, Ljiljana, et al.
Publicado: (2023) -
Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial
por: Moriarty, Patrick M., et al.
Publicado: (2016) -
Coronary artery calcium among patients with heterozygous familial hypercholesterolaemia
por: Tada, Hayato, et al.
Publicado: (2023)